Polyrizon Ltd. (PLRZ) NASDAQ

0.71

-0.0253(-3.42%)

Updated at July 01 03:18PM

Currency In USD

Polyrizon Ltd.

Address

5 Ha-Tidhar Street

Ra'anana, 4366507

Israel

Phone

972 9 374 0120

Sector

Healthcare

Industry

Biotechnology

Employees

2

First IPO Date

October 29, 2024

Key Executives

NameTitlePayYear Born
Mr. Tomer IzraeliFounder, Chief Executive Officer & Director01979
Mr. Nir Ben YosefChief Financial Officer & Compliance Officer01976
Dr. Eyal S. Ron Ph.D.Chief Scientific Officer01955
Ms. Daphna AvitalChief People Officer01967
Dr. Tidhar TurgemanChief Technology Officer01977

Description

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.